statistiche ricercatore

DENTALI, FRANCESCO

Distribuzione geografica

Continente	#
NA - Nord America	33.777
EU - Europa	16.019
AS - Asia	12.303
SA - Sud America	1.449
AF - Africa	229
Continente sconosciuto - Info sul continente non disponibili	37
OC - Oceania	16
Totale	63.830

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	33.374
IT - Italia	7.355
SG - Singapore	4.043
CN - Cina	2.554
UA - Ucraina	2.303
TR - Turchia	1.663
VN - Vietnam	1.594
HK - Hong Kong	1.445
SE - Svezia	1.227
DE - Germania	1.216
BR - Brasile	1.186
IE - Irlanda	808
FI - Finlandia	724
GB - Regno Unito	712
FR - Francia	663
RU - Federazione Russa	508
BD - Bangladesh	286
IN - India	228
CA - Canada	202
MX - Messico	155
NL - Olanda	100
JP - Giappone	99
AR - Argentina	91
PL - Polonia	73
ES - Italia	71
IQ - Iraq	66
ZA - Sudafrica	66
AT - Austria	62
NG - Nigeria	42
PK - Pakistan	42
LT - Lituania	36
BE - Belgio	35
EC - Ecuador	33
ID - Indonesia	30
EU - Europa	29
CL - Cile	28
MA - Marocco	28
SA - Arabia Saudita	28
CO - Colombia	27
VE - Venezuela	27
UZ - Uzbekistan	26
CZ - Repubblica Ceca	21
KE - Kenya	21
IL - Israele	20
MY - Malesia	20
AE - Emirati Arabi Uniti	19
JO - Giordania	18
PY - Paraguay	18
NP - Nepal	16
PH - Filippine	16
AU - Australia	15
EG - Egitto	15
MD - Moldavia	14
BO - Bolivia	13
RO - Romania	13
TN - Tunisia	13
UY - Uruguay	13
CH - Svizzera	12
PE - Perù	12
GR - Grecia	11
PT - Portogallo	11
AZ - Azerbaigian	10
IR - Iran	10
KR - Corea	10
TH - Thailandia	10
DZ - Algeria	9
AL - Albania	8
SN - Senegal	8
CI - Costa d'Avorio	7
ET - Etiopia	7
HN - Honduras	7
LB - Libano	7
TW - Taiwan	7
DO - Repubblica Dominicana	6
HU - Ungheria	6
JM - Giamaica	6
OM - Oman	6
RS - Serbia	6
TT - Trinidad e Tobago	6
CR - Costa Rica	5
KZ - Kazakistan	5
AO - Angola	4
BA - Bosnia-Erzegovina	4
GT - Guatemala	4
KW - Kuwait	4
MK - Macedonia	4
NO - Norvegia	4
XK - ???statistics.table.value.countryCode.XK???	4
A2 - ???statistics.table.value.countryCode.A2???	3
AM - Armenia	3
DK - Danimarca	3
GE - Georgia	3
SV - El Salvador	3
BH - Bahrain	2
BN - Brunei Darussalam	2
BY - Bielorussia	2
DM - Dominica	2
LI - Liechtenstein	2
LK - Sri Lanka	2
NI - Nicaragua	2
Totale	63.799

Salva come PNG Salva come JPEG

Città	#
Milan	5.062
Fairfield	4.108
Ashburn	2.774
Woodbridge	2.671
San Jose	2.665
Singapore	2.211
Houston	1.956
Jacksonville	1.808
Seattle	1.612
Wilmington	1.506
Hong Kong	1.427
Chandler	1.387
Cambridge	1.385
Ann Arbor	1.312
Dallas	879
Izmir	816
Dublin	802
Princeton	787
The Dalles	674
Dearborn	591
Nyköping	539
Beijing	530
Boardman	504
Lauterbourg	421
Dong Ket	367
Chicago	355
Rome	348
Council Bluffs	332
Ho Chi Minh City	312
Munich	301
Los Angeles	285
New York	272
San Diego	247
Helsinki	203
London	197
Hanoi	195
Santa Clara	177
San Mateo	159
Ogden	153
São Paulo	135
Como	127
Orem	115
Washington	109
Guangzhou	107
Mexico City	100
Tokyo	82
Nuremberg	79
Buffalo	75
Frankfurt am Main	74
Montreal	72
Düsseldorf	71
Chennai	68
Hefei	65
Shanghai	63
Redmond	62
Nanjing	60
Brooklyn	57
Verona	57
Warsaw	56
Turku	55
Kunming	54
Norwalk	53
Salt Lake City	53
Tianjin	53
Phoenix	52
Hangzhou	49
Denver	48
Manchester	48
Atlanta	47
Shenzhen	45
Haiphong	44
Paris	44
Toronto	44
Stockholm	41
Abuja	39
Amsterdam	39
Johannesburg	39
Kocaeli	39
San Francisco	39
Boston	38
Rio de Janeiro	38
Varese	38
Belo Horizonte	34
Jinan	34
Elk Grove Village	32
Poplar	31
Da Nang	30
Kilburn	30
Mumbai	30
Brussels	29
Columbus	29
Philadelphia	27
Tampa	27
Zhengzhou	27
Nanchang	25
Tashkent	24
Baghdad	22
Vienna	22
Ankara	21
Changsha	21
Totale	45.498

Salva come PNG Salva come JPEG

Nome	#
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	397
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature	379
Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?	326
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery	312
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study	302
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	301
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature	269
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	267
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	258
Risk of recurrence of unusual site venous thromboembolism	256
ABO blood group and vascular disease: an update	253
Optimal treatment duration of venous thrombosis	251
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism	247
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment	246
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature	246
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency vka anticoagulation reversal	244
Warfarin interactions with antibiotics in the ambulatory care setting	240
incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.	237
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	237
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study	234
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.	230
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	230
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome	230
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice	229
Venous ischemic syndromes	229
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis.	226
A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism	226
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy	224
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	222
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	222
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis	222
Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence	220
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis	219
Patient selection for thromboprophylaxis in medical inpatients	217
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	216
Venous and arterial thrombosis in patients with HIV infection	213
Abdominal obesity and the risk of recurrent deep vein thrombosis.	212
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study	212
Statins, fibrates, and venous thromboembolism: a meta-analysis.	212
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	212
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature	211
Duration of anticoagulation after venous thromboembolism in real world clinical practice	210
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	209
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism.	208
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature	208
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	207
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study	206
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	206
The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature	205
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation	205
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens	203
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy	203
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes	201
Seasonal and monthly variation in occurrence of hypertensive urgency	199
Statins and secondary prevention of ischemic and hemorrhagic stroke	198
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal	198
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage	198
Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians	198
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	197
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis	197
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding	196
sRAGE and early signs of cardiac target organ damage in mild hypertensives	196
Statins for acute ischemic stroke	195
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases	194
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature	194
In vitro effects of Apixaban on 5 different cancer cell lines	194
Risk of Thromboembolism, Recurrent Hemorrhage, and Death after Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding	194
Italian intersociety consensus on DOAC use in internal medicine	193
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation	193
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	192
Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.	192
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation.	192
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis	190
Is diabetes a hypercoagulable state? A critical appraisal	190
Neutrophil-to-lymphocyte ratio: A new prognostic factor even in patients with heart failure	190
5 flourouracil-induced apical ballooning syndrome: a case report.	189
Abdominal pain as pulmonary embolism presentation, usefulness of bedside ultrasound: A report of two cases	189
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study	189
Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study	188
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	188
The role of thrombolytic therapy in pulmonary embolism	187
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events	186
External validation of the DASH prediction rule: a retrospective cohort study	186
Prevention of in-hospital VTE: why can't we do better?	185
Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study	185
Low-molecular -weight heparin in pregnancies after ART -A retrospective study-	185
A CLINICAL ASSESSMENT MODEL TO SELECT ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION FOR A SAFE WARFARIN TREATMENT	184
Atypical case of acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism.	184
Clinical Pregnancies and Live Births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening	184
Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience	184
The effect of thyroid autoantibodies on warfarin stability	184
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.	184
How I treat splanchnic vein thrombosis	183
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.	183
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	183
General practitioner–performed compression ultrasonography for diagnosis of deep vein thrombosis of the leg: A multicenter, prospective cohort study	183
In-hospital mortality due to pulmonary embolism in patients with Alzheimer disease: A sex effect?	182
The prevention and treatment of venous thromboembolism in pregnancy	182
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis.	181
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism: A multicentre retrospective cohort study	181
Totale	21.506

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	278.648
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	278.648

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	876	0	0	0	0	0	0	0	0	0	0	0	876
2021/2022	4.033	403	544	187	104	219	172	325	215	229	726	411	498
2022/2023	4.390	480	206	318	379	303	956	14	576	652	244	140	122
2023/2024	8.221	1.245	1.282	1.286	1.563	1.639	574	66	119	241	95	43	68
2024/2025	6.800	46	52	1.123	178	236	465	373	543	743	705	584	1.752
2025/2026	16.575	1.049	1.000	917	1.983	1.355	881	3.629	1.101	2.024	1.139	948	549
Totale													64.380